Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The American Journal of Pathology
|
December 14, 1999
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
G Bunone, P Vigneri, L Mariani, et al.
Leukemia
|
January 20, 2009
Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells
E K Allan, A Hamilton, S Hatziieremia, et al.
Leukemia Research
|
November 28, 2008
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase
F Stagno, P Vigneri, V Del Fabro, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 1, 1996
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity
A Belfiore, A Costantino, F Frasca, et al.
Leukemia
|
October 20, 2006
The PU.1 transcription factor induces cyclin D2 expression in U937 cells
L Vicari, A Eramo, L Manzella, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1996
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
I Bongarzone, L Fugazzola, P Vigneri, et al.
The American Journal of Surgical Pathology
|
December 31, 1997
Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland
S Pilotti, P Collini, L Mariani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Iodide symporter gene expression in human thyroid tumors
F Arturi, D Russo, M Schlumberger, et al.
Cancer Treatment Reviews
|
October 20, 2024
Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816]
F Schettini, F Gattazzo, S Nucera, et al.
Leukemia Research
|
May 2, 2009
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain
F Stagno, P Vigneri, V Del Fabro, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The American Journal of Pathology
|
December 14, 1999
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
G Bunone, P Vigneri, L Mariani, et al.
Leukemia
|
January 20, 2009
Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells
E K Allan, A Hamilton, S Hatziieremia, et al.
Leukemia Research
|
November 28, 2008
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase
F Stagno, P Vigneri, V Del Fabro, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 1, 1996
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity
A Belfiore, A Costantino, F Frasca, et al.
Leukemia
|
October 20, 2006
The PU.1 transcription factor induces cyclin D2 expression in U937 cells
L Vicari, A Eramo, L Manzella, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1996
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
I Bongarzone, L Fugazzola, P Vigneri, et al.
The American Journal of Surgical Pathology
|
December 31, 1997
Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland
S Pilotti, P Collini, L Mariani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Iodide symporter gene expression in human thyroid tumors
F Arturi, D Russo, M Schlumberger, et al.
Cancer Treatment Reviews
|
October 20, 2024
Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816]
F Schettini, F Gattazzo, S Nucera, et al.
Leukemia Research
|
May 2, 2009
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain
F Stagno, P Vigneri, V Del Fabro, et al.
Page
of 3